You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Mebeverine hydrochloride

Showing 1 - 25 of 1,772
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Irritable Bowel Syndrome With Diarrhea Trial in Karachi (Rifaximin 550 MG, Mebeverine 135 MG, Psyllium Husk)

Active, not recruiting
  • Irritable Bowel Syndrome With Diarrhea
  • Rifaximin 550 MG
  • +3 more
  • Karachi, Sindh, Pakistan
    Bahria University Health Sciences Campus
May 10, 2023

IBS - Irritable Bowel Syndrome, IBS Trial in Belgium (Ebastine, Duspatalin)

Recruiting
  • IBS - Irritable Bowel Syndrome
  • IBS
  • Mechelen, Antwerpen, Belgium
  • +4 more
Apr 4, 2023

Duspatalin® in Post-cholecystectomy Gastrointestinal Spasm

Completed
Has Results
  • Post-cholecystectomy Gastrointestinal Spasms
  • Chita, Russian Federation
  • +20 more
Mar 1, 2019

Functional Bowel Disorder Trial in Moscow (Mebeverine+Simethicone, Mebeverine, Simethicone)

Completed
  • Functional Bowel Disorder
  • Moscow, Russian Federation
    Null Research Facilities
Dec 14, 2021

Diabetic Peripheral Neuropathic Pain Trial in Luoyang (HSK16149 20mg BID)

Recruiting
  • Diabetic Peripheral Neuropathic Pain
  • HSK16149 20mg BID
  • Luoyang, Henan, China
    The First Affiliated Hospital of Henan University of Science and
Nov 2, 2023

Laparoscopy, Anesthesia, Intravenous Trial in China (BT-KTM-I, Ketanest®S)

Not yet recruiting
  • Laparoscopy
  • Anesthesia, Intravenous
  • Guangzhou, Guangdong, China
  • +11 more
Oct 15, 2023

Breast Cancer Trial in Beijing (Mitoxantrone HCl liposome, Capecitabine)

Not yet recruiting
  • Breast Cancer
  • Beijing, Beijing, China
    Cancer Hospital Chinese Academy of Medical Sciences
Dec 1, 2023

Adult Solid Tumor Trial in Rochester (Erlotinib Hydrochloride, Irinotecan Hydrochloride)

Active, not recruiting
  • Adult Solid Neoplasm
  • Erlotinib Hydrochloride
  • Irinotecan Hydrochloride
  • Rochester, Minnesota
    Mayo Clinic in Rochester
Jan 12, 2023

Pain, Insomnia Trial in Guangzhou (Compound ibuprofen polyrelease tablets, reference 1 (R1): Ibuprofen Tablets (Motrin

Not yet recruiting
  • Pain
  • Insomnia
  • Compound ibuprofen polyrelease tablets
  • reference 1 (R1): Ibuprofen Tablets (Motrin IB®)reference 2 (R2): Diphenhydramine Hydrochloride Tablets (Benadryl®)
  • Guangzhou, Guangdong, China
    Zhujiang Hospital of Southern Medical University
Feb 6, 2023

Non Small Cell Lung Cancer, Propranolol Trial (Propranolol HCl, Sintilimab, Chemotherapy)

Not yet recruiting
  • Non Small Cell Lung Cancer
  • Propranolol
  • Propranolol hydrochloride
  • +2 more
  • (no location specified)
Jul 31, 2023

Platinum-resistant Ovarian Cancer Trial in Shanghai (Oral Topotecan Combined With Anlotinib)

Not yet recruiting
  • Platinum-resistant Ovarian Cancer
  • Oral Topotecan Combined With Anlotinib
  • Shanghai, China
    Xinhua Hospital Affiliated to Shanghai Jiaotong University Schoo
Feb 12, 2023

Associated With Cardiomyopathy and Heart Failure After Cancer

Recruiting
  • Hodgkin Lymphoma in Remission
  • +6 more
  • Assessment of Therapy Complications
  • +3 more
  • Birmingham, Alabama
  • +78 more
Jan 11, 2023

Nalbuphine Allergy, Ablation, Safety Trial in China (Nalbuphine, Morphine)

Recruiting
  • Nalbuphine Allergy
  • +2 more
  • Hefei, Anhui, China
  • +19 more
Dec 28, 2022

Myelofibrosis Trial in Changsha (Jaktinib Hydrochloride Tablets)

Not yet recruiting
  • Myelofibrosis
  • Jaktinib Hydrochloride Tablets
  • Changsha, Hunan, China
    The Third Hospital of Changsha
Nov 9, 2023

Nausea and Vomiting Trial in Xi'an (Palonosetron HCl capsules)

Recruiting
  • Nausea and Vomiting
  • Palonosetron hydrochloride capsules
  • Xi'an, Shaanxi, China
    The First Affiliated Hospital, the Air Force Medical University
Jan 18, 2023

Pancreatic Acinar Cell Carcinoma, Pancreatic Ductal Adenocarcinoma, Pancreatic Intraductal Papillary-Mucinous Tumor Trial in

Active, not recruiting
  • Pancreatic Acinar Cell Carcinoma
  • +8 more
  • 3-Dimensional Conformal Radiation Therapy
  • +8 more
  • Mobile, Alabama
  • +697 more
Nov 16, 2022

Oxycodone Sustained-release Tablets for Moderate to Severe

Recruiting
  • Cancer Pain
  • +2 more
    • Zhengzhou, Henan, China
      Henan Cancer Hospital
    Jul 24, 2023

    Pancreatic Adenocarcinoma, Resectable Pancreatic Carcinoma Trial in United States (Fluorouracil, Gemcitabine Hydrochloride,

    Completed
    Has Results
    • Pancreatic Adenocarcinoma
    • Resectable Pancreatic Carcinoma
    • Birmingham, Alabama
    • +806 more
    Oct 18, 2022

    Lymphoma, Solid Tumors Trial in Guangzhou (Mitoxantrone Hydrochloride Liposome)

    Recruiting
    • Lymphoma, Solid Tumors
    • Mitoxantrone Hydrochloride Liposome
    • Guangzhou, Guangdong, China
      Sun Yat-sen University Cancer Center
    Nov 14, 2022

    Acute Myeloid Leukemia, Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome, Atypical Chronic Myeloid

    Active, not recruiting
    • Acute Myeloid Leukemia
    • +9 more
    • Los Angeles, California
    • +5 more
    Jan 27, 2023

    Male Breast Cancer, Recurrent Melanoma, Stage IV Breast Cancer Trial in Columbus (propranolol HCl, Correlative Studies)

    Completed
    • Male Breast Cancer
    • +7 more
    • propranolol hydrochloride
    • Correlative Studies
    • Columbus, Ohio
      Ohio State University Comprehensive Cancer Center
    Dec 4, 2022

    Knee Osteoarthritis Trial in United Kingdom (Liposomal bupivacaine, Bupivacaine HCl)

    Completed
    • Knee Osteoarthritis
    • Liposomal bupivacaine
    • Bupivacaine hydrochloride
    • Birmingham, United Kingdom
    • +10 more
    Nov 3, 2022

    Relapsing Multiple Sclerosis Trial in Beijing (Mitoxantrone Hydrochloride Liposome Injection)

    Not yet recruiting
    • Relapsing Multiple Sclerosis
    • Mitoxantrone Hydrochloride Liposome Injection
    • Beijing, Beijing, China
      Xuanwu Hospital Capital Medical University
    Aug 9, 2022

    Head and Neck Squamous Cell Carcinoma, Pain, Stomatitis Trial in Buffalo (Gabapentin, Methadone Hydrochloride, Oxycodone

    Completed
    • Head and Neck Squamous Cell Carcinoma
    • +2 more
    • Buffalo, New York
      Roswell Park Cancer Institute
    Jul 20, 2022

    Third Molar Extraction Trial in São Paulo (FDC of etoricoxib + cyclobenzaprine + etoricoxib , etoricoxib 90 mg (Arcoxia®) +FDC ,

    Not yet recruiting
    • Third Molar Extraction
    • FDC of etoricoxib + cyclobenzaprine + etoricoxib placebo
    • +2 more
    • São Paulo, SP, Brazil
      Eurofarma Laboratorios S.A
    Jan 11, 2023